Notification for the merger between Achieve Life Sciences, Inc. and OncoGenex Pharmaceuticals

The Company notifies that the merger between Achieve Life Sciences, Inc. and OncoGenex Pharmaceuticals was successfully closed today and as a result of which the stockholders of Achieve have become the majority stockholders of OncoGenex. OncoGenex has been renamed Achieve Life Sciences (NASDAQ: ACHV).

The company announced that "Cytisine is a drug of global public health importance and the transition of Achieve to the public markets is a critical step in advancing our development program,” commented Rick Stewart, Chairman and CEO of Achieve Life Science.

The whole press release may be found at  http://ir.oncogenex.com/releasedetail.cfm?ReleaseID=1030091